The Latest Cardiac and Vascular News
March 19, 2019 08:30 AM Eastern Daylight Time HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf, minimally invasive endovascular repair of Aortic Arch Disease comprising both aneurysms and dissections, today announced that it has received CE-marking for its NEXUS™ Stent Graft System. Diseases of the aortic arch present surgeons with challenging […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today reported financial results for the three and 12 months ended December 31, 2018 and provided a business update. Recent Operational Highlights Signed 19 new DABRA […]
Santa Monica, CA, March 14, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), today announced the closing of a private placement of the Company’s common stock for gross proceeds of approximately $8,620,506. The offering was exempt from registration under Section 4(a)(2) of the United States Securities Act of 1933, as amended, and […]
LAKE OSWEGO, Ore., March 14, 2019 /PRNewswire/ — BIOTRONIK today announced FDA approval of the Acticor and Rivacor high-voltage cardiac rhythm management (CRM) device families for treatment of patients with cardiac arrhythmias. The six new tachycardia solutions include Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX Bipolar and Acticor […]
NEW ORLEANS, March 14, 2019 /PRNewswire/ — Medi-Lynx Cardiac Monitoring, LLC, a leading provider of cardiac monitoring solutions, today announced results from a large retrospective analysis which demonstrated that cardiac monitoring with full-disclosure mobile cardiac telemetry (PocketECG) for up to 30 days significantly increased diagnostic yield for patients with bradyarrhythmia over Patch and […]
LEUVEN, Belgium and HARTFORD, Conn., March 14, 2019 /PRNewswire/ — LindaCare, a digital health company specializing in remote patient monitoring solutions for chronic disease management, today announced the company will offer ProPulse™, a new remote monitoring service for patients with cardiac implantable devices, adding to its online device management software solution. Dr. Robert Lerman, LindaCare’s Chief […]
FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow […]
SILVER SPRING, Md., March 14, 2019 /PRNewswire/ — The U.S. Food and Drug Administration today approved a new indication for a heart valve repair device that is intended to reduce moderate-to-severe or severe mitral regurgitation, a leakage of blood backward through the mitral valve into the heart’s left atrium that can cause […]
ABBOTT PARK, Ill., March 14, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication to its leading MitraClip™ device used to repair a leaky mitral valve without open-heart surgery. Supported by the results of the landmark COAPT™ Trial, […]
OTTAWA, Ontario–(BUSINESS WIRE)–eMurmur today announced the release of eMurmur Heartpedia, an app designed to help patients, parents and medical professionals better understand heart defects through anatomically-correct 3D models and corresponding heart and murmur sound recordings for each defect. eMurmur Heartpedia is a major upgrade to the original Heartpedia app from […]
